Clinical Trial

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

Name: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children — clinical trial record (NCT06347458)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-arm, single-dose dose-escalation and dose-expansion study.

Trial Details

NCT Number	NCT06347458
Lead Sponsor	Guangzhou Bio-gene Technology Co., Ltd
Conditions	Leukemia, Acute Myeloid Leukemia
Enrollment	24 participants
Start Date	2024-04
Primary Completion	2027-04 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2024-04-04